Adjuvant Rituximab-Exploratory Trial in Young People With Graves Disease. (2022)
Attributed to:
Plasma-cell depletion therapy for severe Graves' disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1210/clinem/dgab763
PubMed Identifier: 34687316
Publication URI: http://europepmc.org/abstract/MED/34687316
Type: Journal Article/Review
Volume: 107
Parent Publication: The Journal of clinical endocrinology and metabolism
Issue: 3
ISSN: 0021-972X